InflaRx (IFRX) Other Non-Current Liabilities (2022 - 2025)
InflaRx (IFRX) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $42926.4 as the latest value for Q4 2025.
- Quarterly Other Non-Current Liabilities rose 8.93% to $42926.4 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42926.4 through Dec 2025, up 8.93% year-over-year, with the annual reading at $42926.4 for FY2025, 8.93% up from the prior year.
- Other Non-Current Liabilities hit $42926.4 in Q4 2025 for InflaRx, up from $39406.6 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $42926.4 in Q4 2025 to a low of $37623.7 in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $39908.5 across 4 years, with a median of $39542.0 in 2023.
- Biggest five-year swings in Other Non-Current Liabilities: decreased 0.68% in 2024 and later rose 8.93% in 2025.
- Year by year, Other Non-Current Liabilities stood at $37623.7 in 2022, then increased by 5.46% to $39677.4 in 2023, then dropped by 0.68% to $39406.6 in 2024, then rose by 8.93% to $42926.4 in 2025.
- Business Quant data shows Other Non-Current Liabilities for IFRX at $42926.4 in Q4 2025, $39406.6 in Q4 2024, and $39677.4 in Q4 2023.